Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:2397-2402
doi: 10.1161/CIRCULATIONAHA.105.534545
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lauruschkat, A. H.
Right arrow Articles by Ennker, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lauruschkat, A. H.
Right arrow Articles by Ennker, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Bypass Surgery
*Diabetes
Related Collections
Right arrow Type 2 diabetes
Right arrow CV surgery: coronary artery disease

(Circulation. 2005;112:2397-2402.)
© 2005 American Heart Association, Inc.


Coronary Heart Disease

Prevalence and Risks of Undiagnosed Diabetes Mellitus in Patients Undergoing Coronary Artery Bypass Grafting

Achim H. Lauruschkat, MD; Bert Arnrich, MS; Alexander A. Albert, MD; Jörg A. Walter, PhD; Berthold Amann, MD; Ulrich P. Rosendahl, MD; Tejas Alexander, MD; Jürgen Ennker, MD

From the Departments of Cardiac, Thoracic, and Vascular Surgery (A.A.L., A.A.A., U.P.R., J.E.), and Anaesthesiology (T.A.), Heart Institute Lahr/Baden, Lahr; Neoinformatics Group, Faculty of Technology, Bielefeld University, Bielefeld (B. Arnrich, J.A.W.); and Fraziskus Hospital Berlin, Berlin (B. Amann), Germany.

Correspondence to Dr med Achim H. Lauruschkat, Department of Cardiac, Thoracic, and Vascular Surgery, Heart Institute Lahr/Baden, Hohbergweg 2, 77933 Lahr, Germany. E-mail Lauruschkat{at}heart-lahr.com

Received January 7, 2005; revision received July 23, 2005; accepted July 25, 2005.

Background— Numerous studies have shown that diabetes mellitus (DM) is not identified and, consequently, inadequately treated in a substantial proportion of the patients in the general population. We know very little about the extent and the consequences of undiagnosed diabetes in the risk group of patients with coronary heart diseases. The objective of this study was therefore to determine the prevalence and the risks of undiagnosed DM among patients with coronary artery bypass.

Methods and Results— The data of 7310 patients who have undergone coronary bypass operations between 1996 and 2003 were analyzed. Depending on their diagnosis on admission and their fasting plasma glucose (FPG) level, these patients were classified as known diabetics, undiagnosed diabetics (FPG ≥126 mg/dL), or as nondiabetics (FPG <126 mg/dL) and were compared in terms of their preoperative, intraoperative, and postoperative characteristics. Among the patients with coronary bypass that we examined, we found a prevalence of diagnosed diabetics of 29.6%. The prevalence of patients with undiagnosed DM (FPG ≥126 mg/dL) was 5.2%. In comparison with the other groups (non-DM versus undiagnosed DM versus known DM), the undiagnosed diabetics more frequently required resuscitation (1.7% versus 4.2% versus 1.5%; P<0.01) and reintubation (2.1% versus 5.0% versus 3.5%; P<0.01) and often showed a longer period of ventilation >1 day (5.6% versus 10.5% versus 7.4%; P<0.01). Perioperative mortality rate was highest in this group (0.9% versus 2.4% versus 1.4%; P<0.01).

Conclusions— This study is the first to publish the prevalence of undiagnosed diabetes mellitus in cardiac surgery. During the perioperative and postoperative courses, these patients displayed a substantially higher morbidity and mortality rate.


Key Words: coronary disease • diabetes mellitus • diagnosis • mortality • risk factors




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Emani, B. Ramlawi, N. R. Sodha, J. Li, C. Bianchi, and F. W. Sellke
Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor
J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 185 - 191.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. Knapik, P. Nadziakiewicz, E. Urbanska, W. Saucha, M. Herdynska, and M. Zembala
Cardiopulmonary Bypass Increases Postoperative Glycemia and Insulin Consumption After Coronary Surgery.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1859 - 1865.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Ascione, C.A. Rogers, C. Rajakaruna, and G.D. Angelini
Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac Surgery
Circulation, July 8, 2008; 118(2): 113 - 123.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. H. Lauruschkat, B. Arnrich, A. A. Albert, J. A. Walter, B. Amann, U. P. Rosendahl, T. Alexander, and J. Ennker
Diabetes mellitus as a risk factor for pulmonary complications after coronary bypass surgery.
J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1047 - 1053.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
M. A. Albert, N. Halevy, and E. M. Antman
Preoperative Evaluation for Cardiac Surgery
Card. Surg. Adult, January 1, 2008; 3(2008): 261 - 280.
[Full Text]


Home page
J. Am. Coll. Nutr.Home page
S. Wolfram
Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health
J. Am. Coll. Nutr., August 1, 2007; 26(4): 373S - 388S.
[Abstract] [Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
R. E Anderson, K. Brismar, and T. Ivert
Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines
Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 112 - 116.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
I. Florath, A. Albert, W. Hassanein, B. Arnrich, U. Rosendahl, I. C. Ennker, and J. Ennker
Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters
Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 716 - 721.
[Abstract] [Full Text] [PDF]